Detail of "24738-51-0"
- CAS Number:
- 24738-51-0
- Name:
2,4-Dodecadienamide,N-(2-methylpropyl)-, (2E,4E)-
- Molecular Structure:

- Formula:
- C16H29 N O
- Molecular Weight:
- 251.4076
- Synonyms:
- 2,4-Dodecadienamide,N-(2-methylpropyl)-, (E,E)-; 2,4-Dodecadienamide, N-isobutyl-, (E,E)- (8CI);(2E,4E)-N-(2-Methylpropyl)-2,4-dodecadienamide;(2E,4E)-N-Isobutyldodeca-2,4-dienamide; (E,E)-N-Isobutyl-2,4-dodecadienamide;2,4-(E,E)-Dodecadienoylisobutylamide; Dodeca-2E,4E-dienoic acid isobutylamide;Kalecide; N-Isobutyl-(2E,4E)-dodeca-2,4-dienamide; N-Isobutyldodeca-trans-2,4-dienamide
- Density:
- 0.878g/cm3
- Boiling Point:
- 396.9°Cat760mmHg
- Flash Point:
- 244.2°C
2,4-Dodecadienamide,N-(2-methylpropyl)-, (2E,4E)-

Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- An Echinacea formulation
- An Echinacea formulation. Lehmann, Reg; Bone, Kerry; Penman, Kerry; Matthias, Anita (Mediherb Pty. Ltd., Australia). PCT Int. Appl. WO 2006002493 A1 12 Jan 2006, 41 pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IS, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2. There are some commonly used reagents like 24738-51-0 in this article. CLASS: ICM: A61K035-78. ICS: A61P037-04. APPLICATION: WO 2005-AU993 6 Jul 2005. PRIORITY: AU 2004-903716 7 Jul 2004. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) The present invention relates to an Echinacea formulation which includes an alkylamide fraction comprising a 2-ene alkylamide fraction and a 2,4-diene alkylamide fraction and the wt. ratio of the 2-ene alkylamide fraction to the 2,4-diene alkylamide fraction is between about 1:15 to about 2:1. .

